NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially...
Related Questions
What is the estimated potential financial exposure for GeneDx if the investigation confirms materially false disclosures?
Will this development likely trigger analyst downgrades or increased short‑selling activity in the coming weeks?
How could the securities class action investigation affect GeneDx's short‑term stock price and volume?